Last updated: March 19, 2025
Sponsor: GLYCAR SA (Pty) Ltd
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
GLYCAR Pericardial Patch
Clinical Study ID
NCT05661981
GLYCAR
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients (to be) treated with Glycar Pericardial patch as per IFU and standardclinical practice.
The patient or patient's legal representative signs an EC/ IRB approved informedconsent form prior to the study participation
Intraprocedural inclusion:
GLYCAR Pericardial Patch was implanted, or implantation attempted during the index procedure.
Exclusion
Exclusion Criteria:
- No study specific exclusion criteria: patients treated per standard clinicalpractice and do not present any of the contraindications detailed in the IFU.
Study Design
Total Participants: 110
Treatment Group(s): 1
Primary Treatment: GLYCAR Pericardial Patch
Phase:
Study Start date:
October 09, 2023
Estimated Completion Date:
March 31, 2027
Study Description
Connect with a study center
Marie Lannelongue Hospital
Le Plessis-Robinson,
FranceActive - Recruiting
Leipzig Heart Institute GmbH
Leipzig,
GermanyActive - Recruiting
German Heart Center Munich (Deutsches Herzzentrum München)- Adult Section
Munich,
GermanyActive - Recruiting
German Heart Center Munich (Deutsches Herzzentrum München)- Pediatric Section
Munich,
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.